Zobrazeno 1 - 10
of 3 912
pro vyhledávání: '"Primary Liver Cancer"'
Publikováno v:
Clinical Epigenetics, Vol 16, Iss 1, Pp 1-15 (2024)
Abstract Background DNA methylation biomarkers are one of the most promising tools for the diagnosis and differentiation of adenocarcinomas of the liver, which are among the most common malignancies worldwide. Their differentiation is important becau
Externí odkaz:
https://doaj.org/article/2cd71a963bf54bee8742cfee0dc5bcb0
Publikováno v:
陆军军医大学学报, Vol 46, Iss 19, Pp 2236-2240 (2024)
Objective To construct a prognosis prediction model of primary liver cancer after surgical treatment based on synthetic minority over-sampling technique(SMOTE) algorithm and machine learning model. Methods A retrospective cohort study was conducted o
Externí odkaz:
https://doaj.org/article/af37b258038f44dbb1e066fdf2b2ca63
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-14 (2024)
Abstract Background Portal vein tumor thrombosis (PVTT) commonly occurs in patients with primary liver cancer (PLC). Transarterial chemoembolization (TACE) is a treatment for patients with PLC and PVTT. Some studies have shown that combining TACE the
Externí odkaz:
https://doaj.org/article/d54e55f5d69a4a8297c7b30bd2902f85
Publikováno v:
Journal of the National Cancer Center, Vol 4, Iss 3, Pp 195-202 (2024)
Primary liver cancer is a leading cause of death worldwide. To create advanced treatments for primary liver cancer, studies have utilized models such as 2D cell culture and in vivo animal models. Recent developments in cancer organoids have created t
Externí odkaz:
https://doaj.org/article/590ae18956274698bd448f459a0681e8
Autor:
Xuekai Hu, Jiayun Wei, Pinyan Liu, Qiuxia Zheng, Yue Zhang, Qichen Zhang, Jia Yao, Jingman Ni
Publikováno v:
Cell & Bioscience, Vol 14, Iss 1, Pp 1-23 (2024)
Abstract Primary liver cancer (PLC) is one of the most common malignant gastrointestinal tumors worldwide. Limited by the shortage of liver transplantation donors and the heterogeneity of tumors, patients with liver cancer lack effective treatment op
Externí odkaz:
https://doaj.org/article/6228251549d545eb8ab88d4b9d316313
Publikováno v:
Zhongguo linchuang yanjiu, Vol 37, Iss 8, Pp 1244-1248 (2024)
Objective To construct a predictive model to analyze the diagnostic value of serum alpha fetoprotein (AFP), carcinoembryonic antigen (CEA), heat shock protein 90a (Hsp90a) for primary liver cancer (PHC). Methods A retrospective study was conducted on
Externí odkaz:
https://doaj.org/article/4f31cb87ca9a4273a711d1406c5f294c
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThis study aims to investigate the clinicopathological and ultrasonography characteristics of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) and its correlation with microvascular invasion (MVI), as well as the predictive value of co
Externí odkaz:
https://doaj.org/article/8ac5e2c98b4a49d6b1dc920024e1e4de
Autor:
Jun Xue, Shuai Yang, Si‐Si Zhang, Jun Fan, Zi‐Long Wu, Cheng‐Jun Sui, Yong‐Qiang Yang, Jin‐Feng Zhang, Pian Liu, De‐Jun Zhang, Xin‐Yao Qiu, Tao Zhang, Lei Chen, Gang Wu, Hong‐Yang Wang, Jing Tang
Publikováno v:
Advanced Science, Vol 11, Iss 47, Pp n/a-n/a (2024)
Abstract Immunotherapies employing PD‐1/PD‐L1 immune checkpoint inhibitors (ICIs) are vital for primary liver cancer (PLC), but response rates remain unsatisfying. Accurate differentiation of responders from non‐responders to immunotherapy is i
Externí odkaz:
https://doaj.org/article/d910fc75d24e484495cf1ee35cd05758
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Cellular immunotherapy has shown considerable potential for the treatment of primary liver cancer (PLC), particularly hepatocellular carcinoma (HCC), although it is in the early stages of development. This study used bibliometric methods to delineate
Externí odkaz:
https://doaj.org/article/0dcd9b79b86d4dba8b535658a010d8ee
Publikováno v:
Renal Failure, Vol 46, Iss 1 (2024)
End-stage renal disease (ESRD) coexisted with cirrhosis, ascites, and primary liver cancer represents an extraordinarily rare clinical condition that typically occurs in very late-stage decompensated cirrhosis and is associated with an extremely poor
Externí odkaz:
https://doaj.org/article/d9fa8591acd940dbae8fdd95c758eca9